Objective. Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD). Methods. Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey. Results. Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement? Conclusion. Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.

Additional Metadata
Keywords Measurement, Musculoskeletal health, OMERACT, Pain, Rheumatology
Persistent URL dx.doi.org/10.3899/jrheum.181099, hdl.handle.net/1765/120032
Journal Journal of Rheumatology
Note verschijnt 1 april 2020
Citation
Chiarotto, A, Kaiser, U. (Ulrike), Choy, E. (Ernest), Christensen, R, Conaghan, P.G. (Philip G.), Cowern, M. (Mary), … Mease, P. (2019). Pain measurement in rheumatic and musculoskeletal diseases: Where to go from here? Report from a special interest group at OMERACT 2018. Journal of Rheumatology, 46(10), 355–1359. doi:10.3899/jrheum.181099